---
figid: PMC9006795__bmjopen-2021-058895f01
pmcid: PMC9006795
image_filename: bmjopen-2021-058895f01.jpg
figure_link: /pmc/articles/PMC9006795/figure/F1/
number: Figure 1
figure_title: ''
caption: Concept map depicting four major pathways for the occurrence of CVS following
  aSAH. Inflammatory pathway is shown in yellow and explains how ibuprofen may act
  as a prophylactic agent in this scenario. Numbers in parentheses are representative
  of corresponding reference for that branch, all concept map references are available
  in , part 1. aSAH, aneurysmal subarachnoid haemorrhage; Ca++, Calcium ion; cGMP,
  cyclic guanosine monophosphate; COX, cyclooxygenase; DAG, diacylglycerol; ETA, endothelin
  A; ET, endothelin; Hgb, hemoglobin; ICAM-1, intercellular adhesion molecule-1; IP3,
  inositol trisphosphate; LFA-1, Lymphocyte function-associated antigen 1; Mac-1,
  macrophage-1 antigen; Met, metabolic; MLC 20, Myosin light chain 20; NO, nitric
  oxide; NO-LS, nitric oxide-like substance; PGF2α, prostaglandin F2 alpha; PGs, prostaglandins;
  PKC, protein kinase C; ROS, reactive oxygen species; SA, subarachnoid; TXAs, thromboxanes;
  TXA2, thromboxane A2; VCAM-1, vascular cell adhesion molecule-1.
article_title: 'Aneurysmal subarachnoid haemorrhage—cerebral vasospasm and prophylactic
  ibuprofen: a randomised controlled pilot trial protocol.'
citation: Mojtaba Dayyani, et al. BMJ Open. 2022;12(4):e058895.
year: '2022'

doi: 10.1136/bmjopen-2021-058895
journal_title: BMJ Open
journal_nlm_ta: BMJ Open
publisher_name: BMJ Publishing Group

keywords:
- Stroke
- NEUROSURGERY
- Clinical trials

---
